Treatment of pain in fibromyalgia patients with testosterone gel: Pharmacokinetics and clinical response

International Immunopharmacology

Volumn 27, Issue 2, 2015, Pages 249-256

  White, Hillary D ^a,d   Brown, Lin A J ^a   Gyurik, Robert J ^b   Manganiello, Paul D ^c   Robinson, Thomas D ^d   Hallock, Linda S ^c   Lewis, Lionel D ^a   Yeo, Kiang Teck J ^c,e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b CPEX Pharmaceuticals Inc   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d White Mountain Pharma   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chronic pain; Fibromyalgia; Nociception; Pharmacokinetics; Testosterone

Indexed keywords

TESTOSTERONE; ANALGESIC AGENT; GEL;

ADULT; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; FATIGUE; FEMALE; FIBROMYALGIA; GEL; HORMONE SUBSTITUTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; MINIMUM PLASMA CONCENTRATION; MYALGIA; NOCICEPTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RIGIDITY; TESTOSTERONE BLOOD LEVEL; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE; BLOOD; CHRONIC PAIN; CLINICAL TRIAL; DRUG EFFECTS; INTRADERMAL DRUG ADMINISTRATION; LIBIDO; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ANALGESICS; CHRONIC PAIN; FATIGUE; FEMALE; FIBROMYALGIA; GELS; HUMANS; LIBIDO; MIDDLE AGED; MYALGIA; PILOT PROJECTS; SURVEYS AND QUESTIONNAIRES; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84937162171     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.05.016     Document Type: Article

References (41)

1. M.A. Cathey, F. Wolfe, S.M. Kleinheksel, and D.J. Hawley Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis Am. J. Med. 81 1986 78 84
2. J. Waxman, and S.M. Zatzkis Fibromyalgia and menopause. Examination of the relationship Postgrad. Med. 80 1986 165 167
3. M.B. Yunus, and F. Inanici Fibromyalgia syndrome: clinical features, diagnosis, and biopathophysiologic mechanisms E.S. Rachlin, I.S. Rachlin, Myofascial Pain and Fibromyalgia Second ed. 2002 Mosby Elsevier Science St. Louis 3 31
4. L.J.B. Jaszmann Epidemiology of the climacteric syndrome S. Campbell, The Management of the Menopause and Postmenopausal Years 1976 University Park Press Baltimore 11 23
5. S. Chakrabarty, and R. Zoorob Fibromyalgia Am. Fam. Physician 76 2007 247 254
6. F. Wolfe, K. Ross, J. Anderson, I.J. Russell, and L. Hebert The prevalence and characteristics of fibromyalgia in the general population Arthritis Rheum. 38 1995 19 28
7. D.J. Clauw Fibromyalgia: a clinical review JAMA 311 2014 1547 1555
8. F. Wolfe, D.J. Clauw, M.A. Fitzcharles, D.L. Goldenberg, R.S. Katz, P. Mease, and et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity Arthritis Care Res. 62 2010 600 610
9. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, and et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee Arthritis Rheum. 33 1990 160 172
10. J. Mao Opioid-induced abnormal pain sensitivity Curr. Pain Headache Rep. 10 2006 67 70
11. R. Abs, J. Verhelst, J. Maeyaert, J.P. Van Buyten, F. Opsomer, H. Adriaensen, and et al. Endocrine consequences of long-term intrathecal administration of opioids J. Clin. Endocrinol. Metab. 85 2000 2215 2222
12. J.Y. Xie, D.S. Herman, C.O. Stiller, L.R. Gardell, M.H. Ossipov, J. Lai, and et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance J. Neurosci. 25 2005 409 416
13. R.S. Gregorian, K.A. Golden, A. Bahce, C. Goodman, W.J. Kwong, and Z.M. Khan Antidepressant-induced sexual dysfunction Ann. Pharmacother. 36 2002 1577 1589
14. S.F. Carville, S. Arendt-Nielsen, H. Bliddal, F. Blotman, J.C. Branco, D. Buskila, and et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome Ann. Rheum. Dis. 67 2008 536 541
15. FDA CDER Meeting of the Arthritis Advisory Committee on Fibromyalgia, Transcript June 23, 2003 (http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3967T1.htm)
16. G. Bachmann, J. Bancroft, G. Braunstein, H. Burger, S. Davis, L. Dennerstein, and et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment Fertil. Steril. 77 2002 660 665
17. S.W. Fletcher, and G.A. Colditz Failure of estrogen plus progestin therapy for prevention J. Am. Med. Assoc. 288 2002 366 368
18. Writing Group for the Women's Health Initiative Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial J. Am. Med. Assoc. 288 2002 321 333
19. G.C. Lachelin, M. Barnett, B.R. Hopper, G. Brink, and S.S. Yen Adrenal function in normal women and women with the polycystic ovary syndrome J. Clin. Endocrinol. Metab. 49 1979 892 898
20. I. Sinha-Hikim, S. Arver, G. Beall, R. Shen, M. Guerrero, F. Sattler, and et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women J. Clin. Endocrinol. Metab. 83 1998 1312 1318
21. J.M. Wentworth, M. Agostini, J. Love, J.W. Schwabe, and V.K. Chatterjee St John's wort, a herbal antidepressant, activates the steroid X receptor J. Endocrinol. 166 2000 R11 R16
22. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson, and et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc. Natl. Acad. Sci. U. S. A. 97 2000 7500 7502
23. North-American-Menopause-Society The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society Menopause 12 2005 497 511
24. M.E. Wierman, W. Arlt, R. Basson, S.R. Davis, K.K. Miller, M.H. Murad, and et al. Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline J. Clin. Endocrinol. Metab. 99 2014 3489 3510
25. D. Goldenberg, M. Mayskiy, C. Mossey, R. Ruthazer, and C. Schmid A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia Arthritis Rheum. 39 1996 1852 1859
26. C.S. Burckhardt, S.R. Clark, and R.M. Bennett The fibromyalgia impact questionnaire: development and validation J. Rheumatol. 18 1991 728 733
27. A.H. Heald, A. Butterworth, J.W. Kane, J. Borzomato, N.F. Taylor, T. Layton, and et al. Investigation into possible causes of interference in serum testosterone measurement in women Ann. Clin. Biochem. 43 2006 189 195
28. M.H. Warner, J.W. Kane, S.L. Atkin, and E.S. Kilpatrick Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone Ann. Clin. Biochem. 43 2006 196 199
29. G.A. McCain Fibromyalgia and myofascial pain syndromes P.D. Wall, R. Melzack, Textbook of Pain Third ed. 1994 Churchill Livingstone New York 475 493
30. L.M. Arnold, P.E. Keck Jr., and J.A. Welge Antidepressant treatment of fibromyalgia. A meta-analysis and review Psychosomatics 41 2000 104 113
31. P.G. O'Malley, E. Balden, G. Tomkins, J. Santoro, K. Kroenke, and J.L. Jackson Treatment of fibromyalgia with antidepressants: a meta-analysis J. Gen. Intern. Med. 15 2000 659 666
32. L.M. Arnold, Y. Lu, L.J. Crofford, M. Wohlreich, M.J. Detke, S. Iyengar, and et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arthritis Rheum. 50 2004 2974 2984
33. L.J. Crofford, M.C. Rowbotham, P.J. Mease, I.J. Russell, R.H. Dworkin, A.E. Corbin, and et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial Arthritis Rheum. 52 2005 1264 1273
34. P. Felig, and L.A. Frohman Endocrinology and Metabolism 4th ed. 2001 McGraw Hill 646 647
35. C. Regnier, A. Bennet, D. Malet, T. Guez, M. Plantavid, P. Rochaix, and et al. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma J. Clin. Endocrinol. Metab. 87 2002 3074 3077
36. C.C. Ho, M. Rohaizak, S.Z. Zulkifli, M.A. Siti-Aishah, U. Nor-Aini, and S.H. Sharifah-Noor-Akmal Serum sex hormone levels in pre- and postmenopausal breast cancer patients Singap. Med. J. 50 2009 513 518
37. L.J. Gooren, and E.J. Giltay Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females J. Sex. Med. 5 2008 765 776
38. W.W. Franke, and B. Berendonk Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government Clin. Chem. 43 1997 1262 1279
39. W.B. White, D. Grady, L.C. Giudice, S.M. Berry, J. Zborowski, and M.C. Snabes A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder Am. Heart J. 163 2012 27 32
40. BioSante-Pharmaceuticals-Inc. BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review in Phase III Program http://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-3282504237.html October 11, 2011
41. BioSante-Pharmaceuticals-Inc. BioSante Pharmaceuticals Announces Results from LibiGel® Efficacy Trials http://www.reuters.com/article/2011/12/14/idUS226971+14-Dec-2011+BW20111214 December 14, 2011